[{"Assets_0_Q3_USD":10805613000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1466269000.0,"NetIncomeLoss_1_Q3_USD":594655000.0,"NetIncomeLoss_3_Q3_USD":1624047000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":115088000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":114843000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":108033000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":107828000.0,"StockholdersEquity_0_Q3_USD":7868300000.0,"EarningsPerShareBasic_1_Q3_USD":5.5,"EarningsPerShareBasic_3_Q3_USD":15.06,"EarningsPerShareDiluted_1_Q3_USD":5.17,"EarningsPerShareDiluted_3_Q3_USD":14.14,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":1663496000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":4783003000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20181106"}]